169 related articles for article (PubMed ID: 18665169)
1. The occurrence of invasive cancers following a diagnosis of breast carcinoma in situ.
Robinson D; Holmberg L; Møller H
Br J Cancer; 2008 Aug; 99(4):611-5. PubMed ID: 18665169
[TBL] [Abstract][Full Text] [Related]
2. Second cancers following in situ carcinoma of the breast.
Franceschi S; Levi F; La Vecchia C; Randimbison L; Te VC
Int J Cancer; 1998 Jul; 77(3):392-5. PubMed ID: 9663601
[TBL] [Abstract][Full Text] [Related]
3. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
Wong SM; King T; Boileau JF; Barry WT; Golshan M
Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
[TBL] [Abstract][Full Text] [Related]
4. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
5. Five-year risk of interval-invasive second breast cancer.
Lee JM; Buist DS; Houssami N; Dowling EC; Halpern EF; Gazelle GS; Lehman CD; Henderson LM; Hubbard RA
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25904721
[TBL] [Abstract][Full Text] [Related]
6. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.
Nederend J; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; Louwman MW
Breast Cancer Res; 2012 Jan; 14(1):R10. PubMed ID: 22230363
[TBL] [Abstract][Full Text] [Related]
7. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
Luke C; Priest K; Roder D
Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
[TBL] [Abstract][Full Text] [Related]
8. Synchronous and metachronous bilateral breast cancer: A long-term experience.
Ozturk A; Alco G; Sarsenov D; Ilgun S; Ordu C; Koksal U; Nur Pilanci K; Erdogan Z; Izci F; Elbuken F; Agacayak F; Aktepe F; Ozmen V
J BUON; 2018; 23(6):1591-1600. PubMed ID: 30610782
[TBL] [Abstract][Full Text] [Related]
9. Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast.
Innos K; Horn-Ross PL
Breast Cancer Res Treat; 2008 Oct; 111(3):531-40. PubMed ID: 17978879
[TBL] [Abstract][Full Text] [Related]
10. Morphological types of breast cancer in family members and multiple primary tumours: is morphology genetically determined?
Hemminki K; Granström C
Breast Cancer Res; 2002; 4(4):R7. PubMed ID: 12100745
[TBL] [Abstract][Full Text] [Related]
11. Twenty-year incidence and patterns of contralateral breast cancer after breast conservation treatment with radiation.
Hill-Kayser CE; Harris EE; Hwang WT; Solin LJ
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1313-9. PubMed ID: 16997501
[TBL] [Abstract][Full Text] [Related]
12. The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry.
Claus EB; Stowe M; Carter D; Holford T
Breast; 2003 Dec; 12(6):451-6. PubMed ID: 14659121
[TBL] [Abstract][Full Text] [Related]
13. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
[TBL] [Abstract][Full Text] [Related]
14. Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020).
Nakhlis F; Gilmore L; Gelman R; Bedrosian I; Ludwig K; Hwang ES; Willey S; Hudis C; Iglehart JD; Lawler E; Ryabin NY; Golshan M; Schnitt SJ; King TA
Ann Surg Oncol; 2016 Mar; 23(3):722-8. PubMed ID: 26542585
[TBL] [Abstract][Full Text] [Related]
15. Mammographic density and risk of second breast cancer after ductal carcinoma in situ.
Habel LA; Capra AM; Achacoso NS; Janga A; Acton L; Puligandla B; Quesenberry CP
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2488-95. PubMed ID: 20929881
[TBL] [Abstract][Full Text] [Related]
16. Invasive breast cancer following ductal and lobular carcinoma in situ of the breast.
Levi F; Randimbison L; Te VC; La Vecchia C
Int J Cancer; 2005 Sep; 116(5):820-3. PubMed ID: 15838829
[TBL] [Abstract][Full Text] [Related]
17. Is there a low-grade precursor pathway in breast cancer?
King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
[TBL] [Abstract][Full Text] [Related]
18. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
[TBL] [Abstract][Full Text] [Related]
19. Risk of contralateral breast cancer among women with carcinoma in situ of the breast.
Habel LA; Moe RE; Daling JR; Holte S; Rossing MA; Weiss NS
Ann Surg; 1997 Jan; 225(1):69-75. PubMed ID: 8998122
[TBL] [Abstract][Full Text] [Related]
20. Incidence and risk factors associated with bilateral breast cancer in area with early age diagnosis but low incidence of primary breast cancer: analysis of 10-year longitudinal cohort in Taiwan.
Kuo WH; Yen AM; Lee PH; Hou MF; Chen SC; Chen KM; Chen TH; Chang KJ
Breast Cancer Res Treat; 2006 Sep; 99(2):221-8. PubMed ID: 16544057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
